通过机器学习发现低级别胶质瘤细胞形态学子型的临床意义与分子注释
该研究利用人工智能技术从TCGA-LGG队列的组织学全切片图像中提取细胞形态学生物标志物,通过共识聚类定义细胞形态学亚型(CMS),并在多中心队列中外部验证。预后不良亚型患者对初始及后续治疗反应差,具有高突变负荷、高拷贝数改变频率及高肿瘤浸润淋巴细胞和免疫检查点基因水平,PD-1/PD-L1/CTLA-4高表达经免疫组化证实。
要点
- 基于组织学图像提取的细胞形态学生物标志物可定义低级别胶质瘤的稳健亚型。
- 预后不良亚型患者对初始及后续治疗反应差,且具有高突变负荷和高免疫浸润特征。
- 该亚型框架在低级别胶质瘤中与特定分子改变、免疫微环境、预后和治疗反应相关。
核心结论
- 研究开发并验证了CMS-ML框架,用于发现与特定分子改变、免疫微环境、预后和治疗反应相关的低级别胶质瘤细胞形态学亚型。
研究设计与样本
- 研究为机器学习方法开发与外部验证研究,从TCGA-LGG队列的组织学全切片图像中提取细胞形态学生物标志物,采用共识聚类定义亚型,并在多中心队列中进行外部验证。
主要发现
- 亚型在所有三个独立队列中均具有独立的预测总生存期作用。
- 在TCGA-LGG队列中,预后不良亚型患者对初始及后续治疗反应差。
- 预后不良亚型的低级别胶质瘤具有高突变负荷、高拷贝数改变频率及高水平的肿瘤浸润淋巴细胞和免疫检查点基因。
- 免疫组化染色证实PD-1/PD-L1/CTLA-4水平较高。
- 从低级别胶质瘤学到的亚型对胶质母细胞瘤具有转化影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower-grade gliomas (LGG) are heterogeneous diseases by clinical, histological, and molecular criteria. We aimed to personalize the diagnosis and therapy of LGG patients by developing and validating robust cellular morphometric subtypes (CMS) and to uncover the molecular signatures underlying these subtypes. METHODS: Cellular morphometric biomarkers (CMBs) were identified with artificial intelligence technique from TCGA-LGG cohort. Consensus clustering was used to define CMS. Survival analysis was performed to assess the clinical impact of CMBs and CMS. A nomogram was constructed to predict 3- and 5-year overall survival (OS) of LGG patients. Tumor mutational burden (TMB) and immune cell infiltration between subtypes were analyzed using the Mann-Whitney U test. The double-blinded validation for important immunotherapy-related biomarkers was executed using immunohistochemistry (IHC). RESULTS: We developed a machine learning (ML) pipeline to extract CMBs from whole-slide images of tissue histology; identifying and externally validating robust CMS of LGGs in multicenter cohorts. The subtypes had independent predicted OS across all three independent cohorts. In the TCGA-LGG cohort, patients within the poor-prognosis subtype responded poorly to primary and follow-up therapies. LGGs within the poor-prognosis subtype were characterized by high mutational burden, high frequencies of copy number alterations, and high levels of tumor-infiltrating lymphocytes and immune checkpoint genes. Higher levels of PD-1/PD-L1/CTLA-4 were confirmed by IHC staining. In addition, the subtypes learned from LGG demonstrate translational impact on glioblastoma (GBM). CONCLUSIONS: We developed and validated a framework (CMS-ML) for CMS discovery in LGG associated with specific molecular alterations, immune microenvironment, prognosis, and treatment response.
引用
- Liu XP, Jin X, Seyed Ahmadian S, et al. Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning. Neuro Oncol. 2023. PMID: 35716369. doi:10.1093/neuonc/noac154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。